# Candel Therapeutics, Inc.: Form DEF 14A, filed May 30, 2024

- Company: [Candel Therapeutics, Inc.](/companies/cadl.md) (CIK 1841387)
- Form: DEF 14A
- Filed: 2024-05-30
- Accepted by EDGAR: May 30, 2024, 16:30 ET
- Period: 2024-06-26
- Accession: 0001193125-24-150379
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1841387/000119312524150379/d777600ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1841387/000119312524150379/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1841387/000119312524150379/d777600ddef14a.htm

Filed May 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-150379. Last ingested by Listed: Nov 13, 2026, 16:13 ET. No prices; not investment advice.
